logo

News

hidden spacer image
DNA underlay

Tag: James A Hayward

Acute myeloid leukemia (AML) cells

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-cell Therapy Produced from LineaDNA

December 18th, 2024

Read More

CAR-T hematology UHKT

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA’s Linea DNA™ for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

May 13th, 2024

Read More

alphazyme web

Applied DNA, Alphazyme Agreement for Scale-Up Linea™ RNAP

March 18th, 2024

Read More

Kudo logo

APDN Announces JDA to Integrate Linea™ IVT Platform into Kudo Biotechnology’s mRNA Manufacturing Workflow

December 14th, 2023

Read More

Linea IVD

APDN Announces Linea™ DNA Follow-On Order for Cancer Diagnostic Application

November 28th, 2023

Read More

Micro RNA molecule illustration

APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences

July 18th, 2023

Read More

mRNA

APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform

July 13th, 2023

Read More

speaker at podium

APDN to Present at Upcoming Healthcare Investor Conference

June 8th, 2023

Read More

DNA medical background

APDN Receives Largest Single Purchase Order for LinearDNA To Date

October 10th, 2022

Read More